Testosterone suppression plus enzalutamide versus testosterone suppression plus standard antiandrogen therapy for metastatic hormone-sensitive prostate cancer (ENZAMET): an international, open-label, randomised, phase 3 trial
Titel:
Testosterone suppression plus enzalutamide versus testosterone suppression plus standard antiandrogen therapy for metastatic hormone-sensitive prostate cancer (ENZAMET): an international, open-label, randomised, phase 3 trial
Auteur:
Sweeney, Christopher J Martin, Andrew J Stockler, Martin R Begbie, Stephen Cheung, Leanna Chi, Kim N Chowdhury, Simon Frydenberg, Mark Horvath, Lisa G Joshua, Anthony M Lawrence, Nicola J Marx, Gavin McCaffrey, John McDermott, Ray McJannett, Margaret North, Scott A Parnis, Francis Parulekar, Wendy Pook, David W Reaume, Martin Neil Sandhu, Shahneen K Tan, Alvin Tan, Thean Hsiang Thomson, Alastair Vera-Badillo, Francisco Williams, Scott G Winter, Diana Yip, Sonia Zhang, Alison Y Zielinski, Robert R Davis, Ian D